Proactive Investors - Run By Investors For Investors

TyraTech confirms it is proceeding with Vamousse sale to Alliance Pharma

Tyratech shares were up around 10% on Thursday while Alliance also edged into positive territory
mother looking for head lice in daughter's hair
Alliance will pay US$13mln upfront for the head lice product

TyraTech Inc (LON:TYR) has confirmed that its deal with Alliance Pharma plc (LON:APH) for the sale of the Vamousse branded hair lice treatment will now proceed with immediate effect.

The natural health product company confirmed in a stock market statement that the proposed transaction was approved by shareholders at an AGM yesterday.

Earlier this month, it was agreed that Alliance Pharma would pay up to US$17.5mln for the worldwide rights to Vamousse - with US$13mln coming upfront, followed by US$4.5mln of contingent payments tied to sales milestones.

Tyratech shares were up around 10% on Thursday while Alliance also edged into positive territory.

Alliance chief executive John Dawson said: "The completion of this acquisition provides Alliance a third International star brand with best in class technology.

“There is also real potential for further growth through our substantial global network of distributors."

Following the sale, Tyratech intends to focus on opportunities in the animal health, for control of insects and parasites, where it sees a possible US$6bn market.

View full TYR profile View Profile

TyraTech, Inc. Timeline

Article
March 15 2018
Article
September 12 2017
Article
September 12 2017

Related Articles

woman sun bathing
March 05 2019
The company, which makes a range of cosmetic and beauty products, did well to navigate a tricky first half, and expects to record a “profitable and cash generative” end to its year

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use